AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2009
Mar 6, 2009
30339_dirs_2009-03-06_64b2c3ee-226b-4f8f-90b9-c5aefbcf5246.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-03-05
Reporting Person: GAILEY JOHN R (VP, Gen. Counsel & Sec.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-03-05 | Common Stock | F | 46.7874 | $29.285 | Disposed | 20361.9673 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 676.8182 | Indirect |
| Common Stock | 9349.2204 | Indirect |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27